CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 99 | 113 | 87.6% | |
| CKD 4 | 2008 | 279 | 309 | 90.3% | |
| CKD 5 | 2009 | 36 | 38 | 94.7% | |
| CKD 5 | 2010 | 38 | 41 | 92.7% | |
| CKD 5 | 2011 | 33 | 36 | 91.7% | |
| CKD 5 | 2012 | 48 | 52 | 92.3% | |
| CKD 5 | 2013 | 43 | 47 | 91.5% | |
| CKD003 | 2014 | 54 | 61 | 88.5% | |
| CKD003 | 2015 | 48 | 56 | 85.7% | |
| CKD003 | 2016 | 43 | 49 | 87.8% |
